CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

Halozyme Therapeutics, Inc. Announces Pricing of Upsized Private Offering of $1.3 Billion of Convertible Senior Notes due 2033

Neutral
AI Analysis

Summary

Halozyme Therapeutics announced the pricing of an upsized private offering of $1.3 billion in convertible senior notes due 2033 with a 1.50% interest rate.

Importance:6/10
Sentiment:
0.00
convertible notesdebt offeringcapital raise
Related Companies

Read the original article

Published by PR Newswire Pharma on September 18, 2026 3:20 AM

Read Original